Tilbake til søkeresultatene

PES2020-Prosj.etabl.støtte H2020

Super-Sensitive Particle Despersion ImmunoAssays, preparation for a second stage application for the H2020-PHC-2014-two-stage Program.

Tildelt: kr 89 999

Preparation of a second stage application for the H2020 program, with the call: "Personalising health and care" H2020-PHC-2014-two-stage per 19th of August 2014. Gentian Nanotech AS has made a prototype assay and filed a patent application for the techol ogy in January 2014. Initial work shows that we will be able to prove the technology by inventing commercial assays for two high-value, high-volume, low-concentration, CVD diagnostics: 1: NT-proBNP (heart pumping failure) 2: Troponin (heart muscle infarc tion) The new technology allows for these low-concentration protein biomakers to be measured accuratly, efficiently and at a low cost on existing high-speed, high volume clinical instruments for large-scale automatic testing. This means that we will be able to save lives by giving more accurate results, and by making it possible to test more individuals because of reduced cost and higher efficiency. This PES application will enable us to carry out necessary research to support the H2020 call, and write a strong application to the call "H2020-PHC-2014-two-stage" in the H2020 "Personalizing health and care" program.


PES2020-Prosj.etabl.støtte H2020